Search Results - "Yaya, R."

Synthesis of 3‑Alkyl Oxazolidines, Derived from 2‑Hydroxymethyl Piperidine, as Analytical Standards for the Analysis of Volatile Aldehydes in the Workplace by R. Yaya, Amadou, Girard, Martin, Belkhadem, Karima, Piard, Rémi, Decken, Andreas, Choinière, Catherine, Cloutier, Pierre Luc, Lesage, Jacques, Breau, Livain

“…Hexahydro-3-alkyl-3H-oxazolo­[3,4-a]­pyridines 4–15 for the quantitative analysis of various aldehydes were obtained in good yield via the condensation…”
Get full text

Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study by Custodio, A., Moreno-Rubio, J., Aparicio, J., Gallego-Plazas, J., Yaya, R., Maurel, J., Higuera, O., Burgos, E., Ramos, D., Calatrava, A., Andrada, E., López, R., Moreno, V., Madero, R., Cejas, P., Feliu, J.

“…Oxaliplatin-based chemotherapy (CT), widely used as adjuvant therapy for stage III and selected high-risk stage II colon cancer (CC) patients, is often…”
Get full text

Management of unresectable, locally advanced pancreatic adenocarcinoma by Salgado, M., Arévalo, S., Hernando, O., Martínez, A., Yaya, R., Hidalgo, M.

“…The diagnosis of unresectable locally advanced pancreatic adenocarcinoma (LAPC) requires confirmation, through imaging tests, of the unfeasibility of achieving…”
Get full text

Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain by Hidalgo, M., Álvarez, R., Gallego, J., Guillén-Ponce, C., Laquente, B., Macarulla, T., Muñoz, A., Salgado, M., Vera, R., Adeva, J., Alés, I., Arévalo, S., Blázquez, J., Calsina, A., Carmona, A., de Madaria, E., Díaz, R., Díez, L., Fernández, T., de Paredes, B. G., Gallardo, M. E., González, I., Hernando, O., Jiménez, P., López, A., López, C., López-Ríos, F., Martín, E., Martínez, J., Martínez, A., Montans, J., Pazo, R., Plaza, J. C., Peiró, I., Reina, J. J., Sanjuanbenito, A., Yaya, R., Carrato, Alfredo

“…The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to…”
Get full text

Extended-schedule dose-dense temozolomide in refractory gliomas by Berrocal, A., Perez Segura, P., Gil, M., Balaña, C., Garcia Lopez, J., Yaya, R., Rodríguez, J., Reynes, G., Gallego, O., Iglesias, L.

“…This multicenter phase II study conducted by the Spanish Neuro-Oncology Group evaluated the activity of an extended, dose-dense temozolomide regimen in…”
Get full text

Effect of redox mediator, AQDS, on the decolourisation of a reactive azo dye containing triazine group in a thermophilic anaerobic EGSB reactor by dos Santos, A.B, Cervantes, F.J, Yaya-Beas, R.E, van Lier, J.B

“…The feasibility of thermophilic (55 °C) anaerobic treatment applied to colour removal of a triazine contained reactive azo dye was investigated in two 0.53 l…”
Get full text

Second line chemotherapy with docetaxel in patients with recurrent malignant glioma : a phase II study by SANSON, M, NAPOLITANO, M, YAYA, R, KEIME-GUIBERT, F, BROËT, Ph, HOANG-XUAN, K, DELATTRE, J. Y

“…The objective of the study was to assess the efficacy of docetaxel in recurrent supratentorial malignant gliomas. The sample size of the study was determined…”
Get full text

Synthesis of 17α-substituted ethynylestradiols: Potential ligands for drug vectors by Yaya, Amadou R., Touaibia, Mohamed, Massarweh, Gassan, Rochon, Fernande D., Breau, Livain

“…17α-substituted ethynylestradiols, derived from estrone, were converted to their corresponding 17α-(bromo- or iodo-propargyl)estrone intermediates…”
Get full text

1174P RESUNET (GETNE-2016-01): A phase II study to evaluate the efficacy and safety of the rechallenge with sunitinib in G1/G2 pancreatic neuroendocrine tumours (pNET). A Spanish Task Force Group in neuroendocrine and endocrine tumours (GETNE) study by Grande, E., Espinosa-Olarte, P., Serrano, R., Jimenez, P., Alonso, T., Benavent, M., Castillón, J. Capdevila, Lacasta, A., Tur, R. Yaya, Carmona, A., Gallegos, I., Rodríguez, R.M., Trujillo, A.O. Castillo, Cerrillo, J. Molina, Hernando, J., Martinez, A. Bujedo, Garcia-Carbonero, R.

Get full text

P-43 Ramucirumab effectiveness in patients with advanced gastric cancer or gastro-esophageal junction adenocarcinoma in clinical practice in Spain: Sub-analysis of RAMIS study by Longo, F., Fernandez, M. Jorge, Tur, R. Yaya, Montes, A. Fernández, Lago, N. Martínez, Vázquez, E. Brozos, Urtasun, J. Aparicio, Aldana, G. Quintero, Barbancho, E. Ceballos, Orra, E. Buxó, Muñoz, A. Lopez, Augusto, M. Pellón, Villaverde, R. Molina, Díaz-Paniagua, L., Serdà, P. Cerdà, López-Leiva, P., Martín-Carnicero, A., Castiñeiras, A. Cousillas, Bouzas, L. París, Paredes, B. García, Reinoso, C. Romero, Sedano, M. Ortega

Get full text

Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial by Verger, Eugènia, Gil, Miguel, Yaya, Ricardo, Viñolas, Núria, Villà, Salvador, Pujol, Teresa, Quintó, Llorenç, Graus, Francesc

“…To evaluate the safety profile and efficacy of whole brain radiotherapy (WBRT) concomitantly with temozolomide (TMZ) in patients with brain metastases (BM)…”
Get more information

Chlormethiazole in the management of the opsoclonus-myoclonus syndrome by Vilchez, J J, Lago, A, Burguera, J A, Yaya, R, Casanova, V

“…Two instances of successful treatment of the rare ocular dyskinesia, opsoclonus, with chlormethiazole are reported. A 65-year-old woman had the…”
Get more information

Ramucirumab use in patients with advanced gastric cancer (AGC) or gastro-oesophageal junction (GEJ) adenocarcinoma in Spain: RAMIS observational study by Longo Munoz, F., Jorge Fernandez, M., Yaya Tur, R., Diaz, S., Ortega, M., Dilla, T., Molero, A., Cervera, J.M.

Get full text

793PRamucirumab use in patients with advanced gastric cancer (AGC) or gastro-oesophageal junction (GEJ) adenocarcinoma in Spain: RAMIS observational study by Longo Munoz, F, Jorge Fernandez, M, Yaya Tur, R, Diaz, S, Ortega, M, Dilla, T, Molero, A, Cervera, J M

“…Abstract Background Ramucirumab (RAM), as a single agent, or combined with paclitaxel, is indicated for the treatment of patients with advanced gastric cancer…”
Get full text

793P - Ramucirumab use in patients with advanced gastric cancer (AGC) or gastro-oesophageal junction (GEJ) adenocarcinoma in Spain: RAMIS observational study by Longo Munoz, F., Jorge Fernandez, M., Yaya Tur, R., Diaz, S., Ortega, M., Dilla, T., Molero, A., Cervera, J.M.

“…Ramucirumab (RAM), as a single agent, or combined with paclitaxel, is indicated for the treatment of patients with advanced gastric cancer (AGC) or…”
Get full text

1645O Durvalumab (D) plus tremelimumab (T) for the treatment of patients with progressive, refractory advanced thyroid carcinoma: The DUTHY (GETNE-T1812) trial by Capdevila Castillon, J., Plana, M., Castelo, B., Iglesias, L., Hernando, J., Yaya Tur, R., Baste, N., Carmona-Bayonas, A., Ruiz, S., Trigo, J., Lorenzo-Lorenzo, I., Grande, E., Lorente, D., Ugidos, L., Marquina, G., García-Alvarez, A., Taberna, M., Villamayor, J., Molina-Cerrillo, J., Alonso-Gordoa, T.

Get full text

Efficacy of radiotherapy for malignant gliomas in elderly patients by Villà, S, Viñolas, N, Verger, E, Yaya, R, Martínez, A, Gil, M, Moreno, V, Caral, L, Graus, F

“…Age above 65 years is a strong negative prognostic factor for survival in patients with malignant gliomas (MG) treated with radiotherapy (RT) and its value has…”
Get more information

CpG Island Hypermethylation of the DNA Repair Enzyme Methyltransferase Predicts Response to Temozolomide in Primary Gliomas by PAZ, Maria F, YAYA-TUR, Ricard, SANCHEZ-CESPEDES, Montserrat, GARCIA-VILLANUEVA, Mercedes, ARRIBAS, Leoncio, ESTELLER, Manel, ROJAS-MARCOS, Inigo, REYNES, Gaspar, POLLAN, Marina, AGUIRRE-CRUZ, Lucinda, GARCIA-LOPEZ, Jose Luis, PIQUER, Jose, SAFONT, Maria-Jose, BALANA, Carmen

“…Purpose: The DNA repair enzyme O 6 -methylguanine DNA methyltransferase (MGMT) inhibits the killing of tumor cells by alkylating agents, and its loss in cancer…”
Get full text

Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse by Yung, W.K. Alfred, Prados, Michael D., Yaya-Tur, Ricardo, Rosenfeld, Steven S., Brada, Michael, Friedman, Henry S., Albright, Robert, Olson, Jeffrey, Chang, Susan M., O'Neill, Alison M., Friedman, Allan H., Bruner, Janet, Yue, Nancy, Dugan, Margaret, Zaknoen, Sara, Levin, Victor A.

“…PURPOSE: To determine the antitumor efficacy and safety profile of temozolomide in patients with malignant astrocytoma at first relapse. PATIENTS AND METHODS:…”
Get full text

Temozolamide in previously treated high-grade gliomas patients by Berrocal, A., Reynes, G., Gil, M., Yaya, R., Safont, M.J., De las Peñas, R., Barrajon, E., Gonzalez Junco, C.

Get full text